NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application

Trondl, Robert; Heffeter, Petra; Kowol, Christian R.; Jakupec, Michael A.; Berger, Walter; Keppler, Bernhard K.

doi:10.1039/C3SC53243G

Record: found
Abstract: not found
Article: not found

NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application

Author(s): Robert Trondl , Petra Heffeter , Christian R. Kowol , Michael A. Jakupec , Walter Berger , Bernhard K. Keppler

Publication date (Print): April 2014

Journal: Chem. Sci.

Publisher: Royal Society of Chemistry (RSC)

Read this article at

ScienceOpenPublisher

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Journal ID (publisher-id): CSHCBM

Title: Chem. Sci.

Abbreviated Title: Chem. Sci.

Publisher: Royal Society of Chemistry (RSC)

ISSN (Print): 2041-6520

ISSN (Electronic): 2041-6539

Publication date Created: 2014

Publication date (Print): April 2014

Volume: 5

Issue: 8

Pages: 2925-2932

Article

DOI: 10.1039/C3SC53243G

SO-VID: fc9667b7-e9f3-47d4-89bb-ff81f7bec75d

History

Data availability:

NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application

Read this article at

Related collections

Recursive Rule based Visual Categorization

Author and article information

Journal

Article

History

Comments

Comment on this article

Similar content 4,352

Cited by 106